PI
GSK icon

Putnam Investments’s GSK GSK Stock Holding History

Putnam Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-97,120
Closed -$6.49M – 1481
2014
Q1 		$6.49M Hold
97,120
– – 0.01% 647
2013
Q4 		$6.48M Buy
97,120
+8,720
+10% +$565K 0.02% 632
2013
Q3 		$5.54M Hold
88,400
– – 0.01% 662
2013
Q2 		$5.52M Buy
+88,400
New +$5.61M 0.02% 637

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Putnam Investments's GSK Position: Q2 2014 in Review

Putnam Investments sold out of GSK (GSK) in Q2 2014, closing a stake of 97,120 shares — an estimated $6.49M sold.

Putnam Investments first reported a position in GSK in Q2 2013 and held it in 4 quarters. The position peaked at $6.49M in Q1 2014. 722 funds tracked by Wall St. Rank hold GSK as of Q2 2014.

  • Putnam Investments reported no remaining GSK position as of Q2 2014 after selling out during the quarter.
  • Putnam Investments sold 97,120 GSK shares in Q2 2014, an estimated $6.49M.
  • Putnam Investments first reported a position in GSK in Q2 2013 and held it in 4 quarters.
  • Putnam Investments's GSK position peaked at $6.49M in Q1 2014.
  • 722 funds tracked by Wall St. Rank held GSK as of Q2 2014.

Based on Putnam Investments's 13F filing for Q2 2014, filed 14 Aug 2014.